Lucidi Bruno bought AVIR
June 18, 2026 · Form 4 insider transaction
Lucidi Bruno bought 29,600 shares of Atea Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
29,600
Price
$0.00
Total value
N/A
InsiderLucidi Bruno
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 18, 2026
Filing dateJune 23, 2026
Shares owned after142,350
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.